Related Experiment Video
Updated: May 31, 2026

A Gaze-Contingent Display Framework for Perceptual Learning Research with Simulated Central Vision Loss
Published on: April 11, 2025
Severe visual impairment and blindness in infants: causes and opportunities for control
Parikshit Gogate1, Clare Gilbert, Andrea Zin
1Dr. Gogate's Eye Clinic, Pune, India.
Insights
Early detection of severe visual impairment (SVI) and blindness in infants is crucial for timely treatment and preventing long-term vision loss. Various congenital and acquired conditions can cause SVI in children, necessitating prompt diagnosis and intervention.
Area of Science:
- Ophthalmology
- Pediatrics
- Public Health
Background:
- Childhood blindness significantly impacts a child's development and future opportunities.
- Early detection of severe visual impairment (SVI) and blindness in infants is critical to prevent irreversible amblyopia.
- Causes of SVI and blindness in children are diverse, including congenital anomalies and perinatal/postnatal acquired conditions.
Purpose of the Study:
- To review the causes, diagnosis, and management of severe visual impairment and blindness in infants.
- To emphasize the importance of early detection and intervention for better visual outcomes in children.
- To highlight the roles of various healthcare professionals in identifying and managing pediatric visual impairment.
Main Methods:
- Literature review of causes of SVI and blindness in infants.
- Discussion of diagnostic approaches, including evaluation under anesthesia.
- Overview of treatment strategies for specific pediatric eye conditions.
Main Results:
- Congenital anomalies (anophthalmos, microphthalmos, cataracts, glaucoma, neuro-ophthalmic lesions) and acquired conditions (ophthalmia neonatorum, retinopathy of prematurity, cortical visual impairment) are key causes of infant blindness.
- Leukocoria can indicate serious conditions like congenital cataract, persistent hyperplastic primary vitreous, or retinoblastoma.
- Timely surgical intervention (e.g., for congenital cataracts within 4 months) and management (e.g., screening for retinopathy of prematurity) are vital.
Conclusions:
- Prompt diagnosis and management of infant visual impairment, including conditions presenting with leukocoria, are essential.
- While some conditions have limited treatment options, low vision aids and rehabilitation can significantly benefit affected children.
- Multidisciplinary collaboration among healthcare providers is crucial for sensitive parental complaint evaluation and ensuring adequate follow-up for infant visual health.
Abstract:
Childhood blindness has an adverse effect on growth, development, social, and economic opportunities. Severe visual impairment (SVI) and blindness in infants must be detected as early as possible to initiate immediate treatment to prevent deep amblyopia. Although difficult, measurement of visual acuity of an infant is possible. The causes of SVI and blindness may be prenatal, perinatal, and postnatal. Congenital anomalies such as anophthalmos, microphthalmos, coloboma, congenital cataract, infantile glaucoma, and neuro-ophthalmic lesions are causes of impairment present at birth. Ophthalmia neonatorum, retinopathy of prematurity, and cortical visual impairment are acquired during the perinatal period. Leukocoria or white pupillary reflex can be cause by congenital cataract, persistent hyperplastic primary vitreous, or retinoblastoma. While few medical or surgical options are available for congenital anomalies or neuro-ophthalmic disorders, many affected infants can still benefit from low vision aids and rehabilitation. Ideally, surgery for congenital cataracts should occur within the first 4 months of life. Anterior vitrectomy and primary posterior capsulotomy are required, followed by aphakic glasses with secondary intraocular lens implantation at a later date. The treatment of infantile glaucoma is surgery followed by anti-glaucoma medication. Retinopathy of prematurity is a proliferation of the retinal vasculature in response to relative hypoxia in a premature infant. Screening in the first few weeks of life can prevent blindness. Retinoblastoma can be debulked with chemotherapy; however, enucleation may still be required. Neonatologists, pediatricians, traditional birth attendants, nurses, and ophthalmologists should be sensitive to a parent's complaints of poor vision in an infant and ensure adequate follow-up to determine the cause. If required, evaluation under anesthesia should be performed, which includes funduscopy, refraction, corneal diameter measurement, and measurement of intraocular pressure.
Related Concept Videos
Photoreceptors and Visual Pathways
Glaucoma: Overview
Diabetic Retinopathy
Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...
Angle Closure Glaucoma: Treatment

